Subscribe
Search
Close this search box.
Subscribe
Search
Close this search box.

Belgium, Flanders

ONTOFORCE and Rancho Biosciences Collaborate to Leverage High-Quality Data for Target Identification

Ghent, Belgium, 15 January 2025 – ONTOFORCE, a leader in semantic technology for life sciences, headquartered in Ghent, Belgium, and Rancho Biosciences, the leading data science services company headquartered in San Diego, California, have announced a joint collaboration. This partnership aims to transform high quality data-driven research and drug development, providing scientists with unparalleled insights that drive discovery and innovation in the life sciences.

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities 

Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions. Galapagos will gain full global development and commercialization rights to its pipeline, focusing on accelerating cell therapies and building a global, decentralized manufacturing network. Galapagos to implement a strategic reorganization to position the Company for long-term growth and cell therapy leadership in oncology.

What a year…looking back at Benelux biotech in 2024 

As 2025 comes peeking around the corner, we invite you to look back with us at some of the most exciting science topics we covered this year. From advances in women’s health, organoids, and organ-on-a-chip models to the challenges of data science and innovations in animal science and sustainable biotech; let us walk you through the Benelux life sciences landscape of 2024 as we reflect on the vast amount of knowledge and know-how characteristic to this region.

miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharma Industry.

Leuven, Belgium – December 4th, 2024 – miDiagnostics is pleased to announce the completion of a €30 million Series D funding round, led by Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science. This investment will accelerate the development of a groundbreaking sterility test for batch release and related quality control tests for the BioPharma Industry, utilizing miDiagnostics’ proprietary qPCR technology.

European HealthTech Innovation Needs a Lifeline – Join the Conversation to Drive Change

Ghent, Belgium, 4 December 2024 – European health technology (HealthTech) is at a critical crossroad. Despite groundbreaking research, a thriving startup scene and ambitious talent, the sector struggles to translate innovation into actionable impact. Challenges such as regulatory restrictions, fragmented markets, and funding gaps are slowing progress, while the clock is ticking and other regions of the world are surging ahead.

The Future of Health is Tech

Ghent, Belgium, 4 December 2024 - At MEDVIA, we see the future of HealthTech filled with potential – a future powered by the intersection of health and technology. This is where breakthroughs in healthtech, medtech, AI and digital solutions promise to transform care delivery. It’s where patients have a voice, hospitals and caregivers have access to cutting-edge innovations, and technology like AI is making personalized medicine a reality. That future isn’t distant; it’s already here.

QbD Group announces acquisition of SciencePharma, strengthening global regulatory and quality expertise

Antwerp, Belgium / Warsaw, Poland – December 4, 2024 – QbD Group and SciencePharma have reached an agreement for QbD Group to acquire SciencePharma. The deal is expected to close by early 2025, pending antitrust clearance.

Transforming veterinary research using data science, one paw at a time

Data science is vastly changing the way we do research. Veterinary research is, however, still lagging behind its human counterpart. Why is this the case and can we learn from human health data to close this gap?

Zapping weeds: RootWave’s herbicide-free weed control solution 

RootWave’s technology kills weeds using electricity, offering farmers an eco-friendly alternative to chemical herbicides. The eWeeding solution supports our transition towards a more sustainable agricultural industry, protecting the health of both people and the planet.

Genetic counselors: the heroes behind closed curtains

Would you like the opportunity to explore your genetic predispositions? Genetic testing can be empowering, helping you to make informed decisions about your healthcare. But using DNA analysis to diagnose and predict certain health conditions calls for trained genetic professionals to explain complex results, answer lingering questions and provide emotional support to people, especially when they’re receiving unexpected news. Genetic counselors are an important link in this chain, but their crucial healthcare role is yet to be recognized in Belgium.

Efficient yet accurate life sciences writing, can we AIm for the right balance? 

With the advancements in AI (artificial intelligence) streamlining everything from dentistry to traffic congestion, people in all professions are feeling both excited and uneasy about this increasingly prevalent technology.

4Tissue Raises €2M to Advance Groundbreaking Breast Tissue Replacement Technology

Ghent, October 23, 2024 — 4Tissue, a pioneering biotech company revolutionizing regenerative medicine with its cutting-edge, bioresorbable hydrogel tissue mimic has successfully completed a €2M seed funding round including equity investment and non-dilutive grants. Led by three prominent female investors from the life science and business sectors, this funding will enable 4Tissue to accelerate the clinical development of its innovative platform. This investment underscores the transformative potential of 4Tissue in women’s health.

The rise and recalibration of sustainable agrifood investments: lessons for us all

There has been an unprecedented surge of investments in sustainable agriculture and food technologies in the last decade, but that trend now appears to have reversed into a free fall in funding. This pattern of promise-to-disillusionment perfectly matches the hype cycle previously demonstrated by breakthrough technologies in other sectors. Can we forge a path forward for sustainable agrifood start-ups?

Antibiotic guidelines for food might underestimate the risk for bacterial resistance

Even ‘safe’ levels of antibiotics in food might fuel the next generation of superbugs. Even tiny traces of antibiotics in the meat and fish we eat could contribute to antibiotic resistance. According to research by the Institute of Tropical Medicine (ITM) in Antwerp, as little as one tenth of the amount of antibiotics currently regarded as ‘safe’ by regulators is enough to trigger resistance in bacteria. Now, the scientists are expanding their research, initially performed on wax moth larvae, to mice and humans.

Belgium’s ‘Positive for the Planet’ evolution through agritech

Our current food system is responsible for around a third of global greenhouse gas emissions, extensive deforestation, unsustainable water usage, and an unprecedented loss of biodiversity. Currently, the processes used to produce our food represent an obstacle to limiting average global temperature increases to the levels set out in the Paris Agreement. But are these damaging effects of our current food production landscape an unavoidable cost of feeding humanity or can smart investments in sustainable agritech be part of the solution?